CyberKnife® Treatments
The list below shows a very brief summary of treatments offered, however it must be stressed that not all cases are suitable for CyberKnife radiosurgery and some centres do not offer all treatments. The list is based on current information but is subject to revision from time to time.

Brain
Acoustic neuroma (vestibular schwannoma), meningeoma, haemangioblastoma, jugular foramens tumour, other neuromas, metastases, AVM (ateriovenous malformation), trigeminal neuralgia

Eye
Uveal melanoma

Spine
Metastases, neuromas, meningeomas, haemangioblastomas, MPNST (malignant peripheral nerve sheath tumour).

Body
Certain tumours to the lung, liver, pancreas and prostate. Note that some of these treatments require a multi-modal approach and that CyberKnife® alone may not be sufficient.
CyberKnife treatment areas
Synchrony tumor tracking software
The latest treatment protocols are announced on the manufacturer‘s websites www.cyberknife.com and www.accuray.com.  Please note that MHL is not responsible for any content on those web sites.
For details on treatments offered at the centres which you apply to through MHL visit our dedicated website MHL CyberKnife Service.  You will also find helpful information on how cases are assessed for treatment.
Advanced treatment centres
Non-invasive medical technologies
Private medical centres
Body tumours are treated using the Sychrony® software (left) which allows the CyberKnife to track soft tissue tumors, compensating for natural movement due to breathing and which has extended the range of treatments that can be offered.
Small metal markers are implanted near the tumour and must be allowed to settle for a few days before treatment.  They are not required for brain and spine treatments however where CyberKnife Centres use the 'X-Sight'® software, which allows the CyberKnife to use the patient's own bone structure to provide the necessary markers.
© 2006-2010 Medilux Healthcare Ltd
MHL international web sites
MHL Health
Healthcare for the
Internet Age
MHL
MHL web sites in 26 countries
MHL Health has moved to a new web site
www.mhlhealth.com

Please follow the above link and bookmark our new address in your browser